Biggest News Aggregation in the World
📰 Danielj Oconnor News

Page 3 - Danielj Oconnor News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Danielj Oconnor. Real-time updates on events, politics, business and more.

Larkspur Health Acquisition Corp. Announces Class A Common Stock and Warrants to Commence Trading Se

NEW YORK--(BUSINESS WIRE)--Larkspur Health Acquisition Corp. (NASDAQ: LSPRU, the “Company”) announced that the holders of the Company’s units may elect to separately trade the Class A Common Stock and redeemable warrants underlying such units commencing on February 10, 2022. Those units not separated will continue t...
United States Davids Briones Danielj Oconnor Larkspur Health Holders Of The Company Larkspur Health Acquisition Corp

Police blotter: Poland Village | News, Sports, Jobs

Police activity reported April 22-May 4: May 4, 9:21 a.m. — A truck was speeding recklessly through the lawn at 19 Massachusettes Ave. and an altercation between two men, who both left the scene, was reported. May 2, 7:59 a.m. — Police responded to a call about a suspicious man drinking alcohol in Poland Woods near the bridge. April 29, 11 p.m. — Joshua D. Stephens, 27, 2146 East Park Drive, Uniontown, was cited for excessive speed (74 mph in a 25 mph zone), peeling tires and reckless o...
Danielj Oconnor Jamesm Salvatore Joshuad Stephens Martial Arts Training Center College St Poland Woods
Source: vindy.com

Sirtex Medical announces collaboration update with OncoSec Medical

Sirtex Medical announces collaboration update with OncoSec Medical News provided by Share this article  TAVO™ for the treatment of advanced melanoma WOBURN, Mass., Jan. 19, 2021 /PRNewswire/ -- Sirtex Medical US Holdings, Inc. ("Sirtex"), a leading manufacturer of targeted cancer therapies, announced an advancement in its strategic collaboration with OncoSec Medical, Inc. (NASDAQ: ONCS) relating to OncoSecs lead product candidate TAVO™ (tavokinogene telseplasmid) and its electroporation (...
United States Danielj Oconnor Kevinr Smith Exchange Commission Oncosec Medical Inc Sirtex Pty Ltd

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

OncoSec Announces First Patient Dosed in Phase 2 Trial of TAVO™ Plus OPDIVO® as Neoadjuvant Therapy for Melanoma

OncoSec Announces First Patient Dosed in Phase 2 Trial of TAVO™ Plus OPDIVO® as Neoadjuvant Therapy for Melanoma News provided by Share this article Share this article PENNINGTON, N.J. and SAN DIEGO, Jan. 8, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced the first patient was dosed in OMS-104, an investigator-initiated Phase 2 trial evaluating TAVO™ (tavokinogene telseplasmid), the Companys intratumoral DNA plasmid-based interle...
Patrick Bursey Danielj Oconnor Armada Tarhini Kim Jaffe Oncosec Medical Incorporated The Company Business Development Operations

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science